seed
Stage
1
Investors
About
Maolac is an Israeli company that discovers and develops bioactive proteins and nutritional ingredients derived from colostrum using proteomics, computational biology, and AI. It partners with brands and formulators to supply clinically validated colostrum-based ingredients targeting immunity, gut health, muscle recovery, and longevity.
Explore Maolac's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.